MetLife Investment Management’s Carter's CRI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $702K | Sell |
19,628
-1,675
| -8% | -$60.9K | ﹤0.01% | 1585 |
|
|
2025
Q4 | $691K | Hold |
21,303
| – | – | ﹤0.01% | 1639 |
|
|
2025
Q3 | $601K | Hold |
21,303
| – | – | ﹤0.01% | 1716 |
|
|
2025
Q2 | $642K | Buy |
21,303
+20,665
| +3,239% | +$700K | ﹤0.01% | 1563 |
|
|
2025
Q1 | $26.1K | Buy |
638
+15
| +2% | +$721 | ﹤0.01% | 2736 |
|
|
2024
Q4 | $33.8K | Sell |
623
-18,040
| -97% | -$1.03M | ﹤0.01% | 2774 |
|
|
2024
Q3 | $1.21M | Sell |
18,663
-544
| -3% | -$34.9K | 0.01% | 1283 |
|
|
2024
Q2 | $1.19M | Sell |
19,207
-1,006
| -5% | -$69.9K | 0.01% | 1253 |
|
|
2024
Q1 | $1.71M | Sell |
20,213
-533
| -3% | -$42.3K | 0.01% | 1030 |
|
|
2023
Q4 | $1.55M | Sell |
20,746
-596
| -3% | -$41.4K | 0.01% | 1072 |
|
|
2023
Q3 | $1.48M | Sell |
21,342
-1,226
| -5% | -$87.6K | 0.01% | 1036 |
|
|
2023
Q2 | $1.64M | Sell |
22,568
-815
| -3% | -$55.1K | 0.01% | 1015 |
|
|
2023
Q1 | $1.68M | Sell |
23,383
-626
| -3% | -$47.9K | 0.01% | 978 |
|
|
2022
Q4 | $1.79M | Sell |
24,009
-1,016
| -4% | -$72.8K | 0.01% | 947 |
|
|
2022
Q3 | $1.64M | Sell |
25,025
-1,158
| -4% | -$88.7K | 0.01% | 964 |
|
|
2022
Q2 | $1.85M | Sell |
26,183
-1,134
| -4% | -$91.3K | 0.01% | 931 |
|
|
2022
Q1 | $2.51M | Buy |
27,317
+6,834
| +33% | +$642K | 0.02% | 906 |
|
|
2021
Q4 | $2.07M | Sell |
20,483
-660
| -3% | -$67.3K | 0.02% | 859 |
|
|
2021
Q3 | $2.06M | Sell |
21,143
-821
| -4% | -$82.9K | 0.02% | 845 |
|
|
2021
Q2 | $2.27M | Sell |
21,964
-791
| -3% | -$80.6K | 0.02% | 828 |
|
|
2021
Q1 | $2.02M | Sell |
22,755
-1,130
| -5% | -$105K | 0.02% | 863 |
|
|
2020
Q4 | $2.25M | Sell |
23,885
-1,098
| -4% | -$96.6K | 0.02% | 768 |
|
|
2020
Q3 | $2.16M | Sell |
24,983
-916
| -4% | -$76.3K | 0.02% | 685 |
|
|
2020
Q2 | $2.09M | Buy |
25,899
+558
| +2% | +$44.4K | 0.02% | 702 |
|
|
2020
Q1 | $1.67M | Hold |
25,341
| – | – | 0.02% | 682 |
|
|
2019
Q4 | $2.77M | Sell |
25,341
-680
| -3% | -$68.9K | 0.03% | 670 |
|
|
2019
Q3 | $2.37M | Sell |
26,021
-764
| -3% | -$69.6K | 0.03% | 715 |
|
|
2019
Q2 | $2.61M | Sell |
26,785
-966
| -3% | -$94.1K | 0.03% | 683 |
|
|
2019
Q1 | $2.8M | Sell |
27,751
-205
| -0.7% | -$18.3K | 0.03% | 656 |
|
|
2018
Q4 | $2.28M | Sell |
27,956
-494
| -2% | -$44.9K | 0.03% | 699 |
|
|
2018
Q3 | $2.81M | Sell |
28,450
-1,052
| -4% | -$111K | 0.03% | 704 |
|
|
2018
Q2 | $3.2M | Sell |
29,502
-30
| -0.1% | -$3.23K | 0.04% | 562 |
|
|
2018
Q1 | $3.07M | Sell |
29,532
-410
| -1% | -$47.7K | 0.04% | 598 |
|
|
2017
Q4 | $3.52M | Buy |
+29,942
| New | +$3.1M | 0.04% | 541 |
|
Other funds holding CRI
VPM
RI
VCM
MetLife Investment Management's CRI Position: Q1 2026 in Review
MetLife Investment Management reduced its Carter's (CRI) stake by 7.9% in Q1 2026, selling an estimated $60.9K and leaving 19,628 shares worth $702K. The position accounts for ﹤0.01% of the portfolio, ranked #1585.
MetLife Investment Management first reported a position in CRI in Q4 2017 and has held it in 34 quarters since. The position peaked at $3.52M in Q4 2017. 275 funds tracked by Wall St. Rank hold CRI as of Q1 2026.
- MetLife Investment Management held 19,628 shares of Carter's worth $702K as of Q1 2026.
- MetLife Investment Management sold 1,675 Carter's shares in Q1 2026, an estimated $60.9K.
- Carter's made up ﹤0.01% of MetLife Investment Management's portfolio in Q1 2026, its #1585 holding.
- MetLife Investment Management first reported a position in Carter's in Q4 2017 and has held it in 34 quarters since.
- MetLife Investment Management's Carter's position peaked at $3.52M in Q4 2017.
- 275 funds tracked by Wall St. Rank held Carter's as of Q1 2026.
Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.